Beyond Air, Inc. Derivative Asset, Fair Value, Gross Asset
Beyond Air, Inc. (XAIR) had Derivative Asset, Fair Value, Gross Asset of $6.54 million as of 2019-03-31, per its 10-K filed 2019-06-28.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeAsset · last filed 2019-06-28
- 2019-03-31: Derivative Asset, Fair Value, Gross Asset $6.54M.
- 2018-12-31: Derivative Asset, Fair Value, Gross Asset $3.07M.
- 2018-03-31: Derivative Asset, Fair Value, Gross Asset $9.04M.
| Period end | Derivative Asset, Fair Value, Gross Asset |
|---|---|
| 2019-03-31 | $6.54M 10-K · filed 2019-06-28 |
| 2018-12-31 | $3.07M 10-Q · filed 2019-02-14 |
| 2018-03-31 | $9.04M 10-Q · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |